BRPI0704182A2 - pharmaceutical composition, process for preparing said composition and use thereof - Google Patents

pharmaceutical composition, process for preparing said composition and use thereof

Info

Publication number
BRPI0704182A2
BRPI0704182A2 BRPI0704182A BRPI0704182A2 BR PI0704182 A2 BRPI0704182 A2 BR PI0704182A2 BR PI0704182 A BRPI0704182 A BR PI0704182A BR PI0704182 A2 BRPI0704182 A2 BR PI0704182A2
Authority
BR
Brazil
Prior art keywords
composition
pharmaceutical composition
preparing
prophylaxis
pharmaceutical
Prior art date
Application number
Other languages
Portuguese (pt)
Inventor
Dante Alario Jr
Costa Pereira Jose Roberto Da
Original Assignee
Biolab Sanus Farmaceutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolab Sanus Farmaceutica Ltda filed Critical Biolab Sanus Farmaceutica Ltda
Priority to BRPI0704182 priority Critical patent/BRPI0704182A2/en
Publication of BRPI0704182A2 publication Critical patent/BRPI0704182A2/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

COMPOSIçãO FARMACêUTICA, PROCESSO DE PREPARAçãO DA REFERIDA COMPOSIçãO E USO DA MESMA. A presente invenção refere-se a uma composição farmacêutica para profilaxia de anomalias fetais, ocasionadas pelo mau fechamento do tubo neural e ainda para a profilaxia de doenças neurológicas e/ou cognitivas, tais como Alzheimer e demência senil entre outras. A referida composição consiste na associação das substâncias de seu princípio ativo em uma única forma farmacêutica. Adicionalmente, a presente concretização refere-se a um processo de preparação da referida composição farmacêutica e ao uso da mesma.PHARMACEUTICAL COMPOSITION, PREPARATION PROCESS FOR SUCH COMPOSITION AND USE. The present invention relates to a pharmaceutical composition for prophylaxis of fetal anomalies caused by poor neural tube closure and for the prophylaxis of neurological and / or cognitive diseases such as Alzheimer's and senile dementia among others. This composition consists in the association of the substances of its active principle in a single pharmaceutical form. Additionally, the present embodiment relates to a process for preparing said pharmaceutical composition and the use thereof.

BRPI0704182 2007-09-25 2007-09-25 pharmaceutical composition, process for preparing said composition and use thereof BRPI0704182A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0704182 BRPI0704182A2 (en) 2007-09-25 2007-09-25 pharmaceutical composition, process for preparing said composition and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0704182 BRPI0704182A2 (en) 2007-09-25 2007-09-25 pharmaceutical composition, process for preparing said composition and use thereof

Publications (1)

Publication Number Publication Date
BRPI0704182A2 true BRPI0704182A2 (en) 2009-05-26

Family

ID=40671625

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0704182 BRPI0704182A2 (en) 2007-09-25 2007-09-25 pharmaceutical composition, process for preparing said composition and use thereof

Country Status (1)

Country Link
BR (1) BRPI0704182A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016123076A1 (en) * 2015-01-27 2016-08-04 La Vita Compounding Pharmacy Stable 5-methyltrahydrofolate formulations to moderate methylenetetrahydrofolate reductase associated polymorphisms

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016123076A1 (en) * 2015-01-27 2016-08-04 La Vita Compounding Pharmacy Stable 5-methyltrahydrofolate formulations to moderate methylenetetrahydrofolate reductase associated polymorphisms
US10406159B2 (en) 2015-01-27 2019-09-10 La Vita Compounding Pharmacy Stable 5-methyltetrahydrofolate formulations to moderate methylenetetrahydrofolate reductase associated polymorphisms
US10849905B2 (en) 2015-01-27 2020-12-01 La Vita Compounding Pharmacy Stable 5-methyltetrahydrofolate formulations to moderate methylenetetrahydrofolate reductase associated polymorphisms

Similar Documents

Publication Publication Date Title
CL2018001089A1 (en) Valbenazine salts and polymorphs thereof.
BR112013017779A2 (en) oxazine derivatives and their use in the treatment of neurological disorders
ECSP12011622A (en) OXAZINE DERIVATIVES AND ITS USE AS BACE INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
BR112013032974A2 (en) "1,6-diazabicyclo [3,2,1] -octan-7-one derivatives, their uses, and pharmaceutical compositions".
BRPI0608840B8 (en) pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea, and its preparation process
BR112012015916A2 (en) Pyrazine derivatives and their use in the treatment of neurological disorders
BR112015014458A8 (en) mannose derivatives, their intermediates, composition, use and preparation processes
BR112014011162A2 (en) purine derivatives for the treatment of viral infections
UY33241A (en) ? Tienopyrimidines containing heterocycloalkyl for pharmaceutical compositions ?.
BR112015020772A2 (en) pyrimidine and pyridine compounds and their use
BR112012012529A2 (en) indole compound and its pharmaceutical use
BR112013006344A2 (en) piperdinyl substituted lactams as gpr119 modulators, pharmaceutical composition comprising them, use and process for preparing same
BR112013007457A8 (en) PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN, PROCESSES FOR OBTAINING THEM AND METHOD OF TREATMENT OF INTESTINAL DISEASE
BRPI0806400A8 (en) compound, pharmaceutical composition, products, uses of at least one compound, in vitro method, kit, binders and process for preparing a compound
UY34239A (en) FENIL-3-AZA-BICICLO [3,1,0] HEX-3-IL-METANONAS AND ITS USE AS A MEDICINAL PRODUCT
BR112014018767A8 (en) FUSED PYRROLDICARBOXAMIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITION INCLUDING THEM
BR112014001908A2 (en) substituted heterocyclic aza derivatives
ECSP11010956A (en) COMPOUNDS LINKED WITH SULFUR FOR THE TREATMENT OF DISEASES AND OPHTHALMIC DISORDERS
BR112019011462A2 (en) gip / glp-1 coagonist peptide; and, peptide for use in the treatment and / or prophylaxis of clinical alzheimer's disease.
AR084832A1 (en) OXAZINE CRYSTAL DERIVATIVE
DOP2013000314A (en) TYPICAL OPHTHALMOLOGICAL PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB
BR112015030774A2 (en) new compounds for cancer treatment
BR112015030678A8 (en) 4-amino-6-phenyl-5,6-dihydroimidazo [1,5-a] pyrazine derivatives as beta-secretase (bace) inhibitors, pharmaceutical composition, process for preparing the same, and uses in the manufacture of medicines
GT200700097A (en) NEW DERIVATIVES OF PHENYLPIRIDINYLPIPERAZINE, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BRPI1011851A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, AND METHODS FOR INDUCING APOPTOSIS IN A CELL, AND TO TREAT A DISEASE

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06V Preliminary requirement: patent application procedure suspended [chapter 6.22 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Decision: refusal
B12B Appeal: appeal against refusal